SQA Regulatory Surveillance Summary | Monthly Update 2022 – September/October
SQA
DECEMBER 16, 2022
This proposal builds upon the existing legal framework, which came into force in 2002 for blood and 2004 for tissues and cells. It also fosters innovation in this crucial biotech sector. The framework contains parallel provisions for donor selection, quality and safety management and oversight.
Let's personalize your content